DRUGS MADE IN AMERICA ACQUISITION CORP. (DMAAR) Capital expenditures
DRUGS MADE IN AMERICA ACQUISITION CORP. (DMAAR) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
No annual history for this metric yet
The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.
← Back to DMAARSource: SEC XBRL filings · For reference only · Not investment advice
More DMAAR financial trends
DMAAR RevenueDMAAR Net incomeDMAAR Net marginDMAAR Gross profitDMAAR Gross marginDMAAR Operating incomeDMAAR Operating marginDMAAR Operating cash flowDMAAR Free cash flowDMAAR Return on equityDMAAR Stock buybacksDMAAR Dividends paidDMAAR Total assetsDMAAR Total liabilitiesDMAAR Shareholders’ equityDMAAR overview →